Compare KVUE & HUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KVUE | HUM |
|---|---|---|
| Founded | 2022 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.1B | 28.2B |
| IPO Year | 2023 | 1993 |
| Metric | KVUE | HUM |
|---|---|---|
| Price | $17.47 | $207.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 18 |
| Target Price | $20.00 | ★ $290.35 |
| AVG Volume (30 Days) | ★ 44.8M | 1.4M |
| Earning Date | 02-06-2026 | 02-11-2026 |
| Dividend Yield | ★ 4.74% | 1.70% |
| EPS Growth | ★ 35.31 | N/A |
| EPS | 0.75 | ★ 10.68 |
| Revenue | $15,006,000,000.00 | ★ $126,362,000,000.00 |
| Revenue This Year | N/A | $10.84 |
| Revenue Next Year | $2.74 | $12.23 |
| P/E Ratio | $23.40 | ★ $19.47 |
| Revenue Growth | N/A | ★ 9.87 |
| 52 Week Low | $14.02 | $206.21 |
| 52 Week High | $25.17 | $315.35 |
| Indicator | KVUE | HUM |
|---|---|---|
| Relative Strength Index (RSI) | 55.09 | 22.13 |
| Support Level | $17.42 | $269.21 |
| Resistance Level | $17.89 | $274.72 |
| Average True Range (ATR) | 0.35 | 8.41 |
| MACD | 0.05 | -5.49 |
| Stochastic Oscillator | 67.09 | 1.50 |
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.